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†Department of Bioengineering, University of Washington, Seattle, WashingtonABSTRACT Prion diseases involve the conformational conversion of the cellular prion protein (PrPC) to its misfolded patho-
genic form (PrPSc). To better understand the structural mechanism of this conversion, we performed extensive all-atom,
explicit-solvent molecular-dynamics simulations for three structures of the wild-type human PrP (huPrP) at different pH values
and temperatures. Residue 129 is polymorphic, being either Met or Val. Two of the three structures have Met in position 129 and
the other has Val. Lowering the pH or raising the temperature induced large conformational changes of the C-terminal globular
domain and increased exposure of its hydrophobic core. In some simulations, HA and its preceding S1-HA loop underwent large
displacements. The C-terminus of HB was unstable and sometimes partially unfolded. Two hydrophobic residues, Phe-198 and
Met-134, frequently became exposed to solvent. These conformational changes became more dramatic at lower pH or higher
temperature. Furthermore, Tyr-169 and the S2-HB loop, or the X-loop, were different in the starting structures but converged to
common conformations in the simulations for the Met-129, but not the Val-129, protein. a-Strands and b-strands formed in the
initially unstructured N-terminus. a-Strand propensity in the N-terminus was different between the Met-129 and Val129 proteins,
but b-strand propensity was similar. This study reveals detailed structural and dynamic properties of huPrP, providing insight into
the mechanism of the conversion of PrPC to PrPSc.INTRODUCTIONPrion diseases are a group of fatal neurodegenerative disor-
ders, including Creutzfeldt-Jakob disease, Gerstmann-
Stra¨ussler-Scheinker syndrome, fatal familial insomnia,
and kuru in humans; scrapie in sheep; bovine spongiform
encephalopathy in cattle; and chronic wasting disease in cer-
vids (1,2). According to the protein-only hypothesis, prion
diseases are caused by the conformational conversion of
the cellular prion protein (PrPC) to its misfolded pathogenic
form (PrPSc) (3,4). Once formed, PrPSc acts as a template to
catalyze the conversion of PrPC to PrPSc, resulting in accu-
mulation of PrPSc. Most cases of prion diseases in humans
are sporadic, which means that PrPC spontaneously converts
to PrPSc in vivo or is transmitted in an unidentified manner
(1,2).
Structures of PrPC have been solved for multiple species
(5–15). These structures are very similar: the N-terminal
portion is largely unstructured and the C-terminal region
contains the folded, globular domain (Fig. 1 A). The C-ter-
minal domain consists of three a-helices (HA, HB, and HC)
and a short b-sheet with two strands (S1 and S2). PrPSc has
the same primary structure as PrPC but a different fold (16).
During the conversion of PrPC to PrPSc, the a-helix content
decreases somewhat but the b-sheet content increases
greatly (17,18). Also, whereas PrPC is protease sensitive,
PrPSc contains a protease-resistant core of residuesSubmitted July 23, 2013, and accepted for publication December 26, 2013.
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0006-3495/14/03/1152/12 $2.00~90–230 (19). An experimentally derived PrPSc structure
has been elusive, but several models of PrPSc have been pro-
posed (20–24).
Molecular-dynamics (MD) simulations have been em-
ployed to study the conversion of PrPC to PrPSc (25). For
instance, growth of the native b-sheet of PrPC has been
observed in MD simulations under acidic conditions
(21,26–29). The converted structures were used to build spi-
ral models of early aggregates of PrPSc (21,23). MD simula-
tions of PrP mutants show that disease-linked point
mutations have varied effects on the structure of PrPC
(30–42). In simulations under harsh nonphysiological con-
ditions (e.g., very high temperature and/or very low pH),
the globular domain of PrPC unfolds and new b-sheets
form (43–45).
The structure of human PrPC (huPrPC) was first obtained
by NMR (8,46). Most previous MD simulations of huPrPC
were based on these NMR structures (28–30,32,35,36,38–
44,47). Later, the structure of huPrPC was also solved by
x-ray crystallography (48–50). Although the overall struc-
ture of huPrPC in the crystals is similar to that derived by
NMR, differences exist in local regions such as the X-loop
between S2 and HB, which is part of an epitope for a
PrPSc-specific monoclonal antibody (51) and hypothetical
protein X binding partner (52) (Fig. 1). To further investi-
gate the structural and dynamic properties of huPrPC, and
how these properties factor into the conversion of PrPC to
PrPSc, we performed extensive MD simulations for two
newly solved crystal structures of huPrPC (Protein Data
Bank (PDB) codes 2W9E and 3HAK) (49,50) along with
the first NMR structure of huPrPC (PDB code 1QLX)
(8). In all three cases, we added the missing N-terminal res-
idues 90–127 to yield conversion-competent constructs.http://dx.doi.org/10.1016/j.bpj.2013.12.053
Properties of huPrP 1153Simulations were carried out at neutral pH (pH 7) or mildly
acidic pH (pH ~5) at 298 and 310 K. pH 5 is similar to the
pH of endosomes (53), where the conversion of PrPC to
PrPSc occurs (54,55). Simulations at 298 K were performed
for comparison with in vitro experiments, whereas 310 K is
physiological temperature. In the simulations, various parts
of the C-terminal globular domain were unstable and under-
went conformational changes, which was facilitated at
lower pH or higher temperature. The X-loop was different
in the starting structures but converged to a common confor-
mation in the simulations of the two structures with
Met-129. Furthermore, b-strands and a-strands (variations
of b-strands in which there is a peptide plane flip that results
in the carbonyl oxygens being aligned on one face and the
NH groups on the other (38)) spontaneously formed in the
N-terminal tail, a key step in the conversion of PrPC to
PrPSc. These results shed light on the mechanism of the con-
version of PrPC to PrPSc and show that the results are inde-
pendent of the starting structure.MATERIALS AND METHODS
One NMR structure (PDB code 1QLX) (8) and two crystal structures (PDB
codes 2W9E and 3HAK) (49,50) were used as the starting structures for
simulations of huPrP. Molecules other than huPrP (e.g., waters and/or anti-
body in PDB 2W9E) in these PDB files were excluded. The missing
N-terminal tail (residues 90–127) and C-terminus (residues 229–230) in
the 1QLX structure were modeled as described previously (29). Then, the
same N-terminal tail was added to the two crystal structures. Addition of
these N-terminal residues is necessary to yield a conversion-competent
construct. The missing C-terminus of HC in the two crystal structures
was added using the corresponding portion of the structure of PDB
1QLX. As a result, three structures of huPrP containing residues 90–230
were obtained (Fig. 1 C). All simulations reported here were for proteins
containing residues 90–230, which corresponds to the PrPSc fragments
associated with infectivity and isolated from brains. For simulations at
pH 7, the His residues were protonated on N
ε
except for His-140, which
was protonated on Nd because of its neighboring residues (56). For simula-
tions at pH 5, the His residues were double protonated on both Nd and Nε,
and all titratable side chains were charged.FIGURE 1 Comparison of three structures (1QLX, 2W9E, and 3HAK) of h
RMSD of the backbone (N, Ca, C, and O atoms) of each residue between ea
(C) Starting structure of huPrP for simulations. The core region of the C-term
218) is highlighted. The hydrophobic core of the globular domain (residues 13
209, 210, and 213–215) is represented as a translucent surface, with every residWe performed the MD simulations using our in-house-developed molec-
ular modeling package in lucem molecular mechanics (ilmm) (57). The
Levitt et al. (58) protein force field and the F3C water model (59) were
used. A force-shifted nonbonded cutoff of 10 A˚ was used and the
nonbonded list was updated every two steps. The starting structures of
huPrP were first energy minimized by 1000 steps of the steepest-descent
method in vacuo. Then, the proteins were solvated in rectangular water
boxes preequilibrated to the appropriate density of the target temperature
(60). After that, 1000 steps of steepest-descent minimization, 500 steps
of MD, and 500 steps of minimization were performed sequentially for
only water, followed by 500 steps of minimization for only the protein.
Finally, production MD simulations were executed in the microcanonical
ensemble (constant volume, total energy, and number of particles) at pH
7 or 5 at 298 and 310 K. Three simulations were performed for each struc-
ture for each condition. Each simulation was carried out for 100 ns using a
2 fs time step, amounting to a total of 36 simulations and 3.6 ms of simula-
tion time.
We analyzed MD trajectories using ilmm (57) and VMD (61). The Ca
root mean-square deviation (RMSD) of the globular domain (residues
128–228) was measured after alignment on the globular domain. The Ca
RMSD of HA was calculated after alignment on the two disulfide-bonded
helices (HB and HC, residues 175–187 and 206–218, referred to as the
core region of the globular domain) (62). The solvent-accessible surface
area (SASA) was calculated with a probe of 1.4 A˚ radius according to
the Lee and Richards (63) method and the van der Waals radii of Chothia
(64). The Dictionary of Secondary Structure of Proteins (DSSP) algorithm
(65) with additional definitions (23) was used to assign secondary struc-
tures. An atom-atom contact was tallied if the distance between two
nonbonded carbon atoms was %5.4 A˚ or the distance between any other
pair of nonbonded nonhydrogen atoms was%4.6 A˚.RESULTS AND DISCUSSION
We selected one NMR structure (PDB code 1QLX) (8) and
two crystal structures of huPrP (PDB codes 2W9E and
3HAK) for this study (49,50). In the 2W9E structure, huPrP
is bound to an antibody, which was removed for the simula-
tions. A single-nucleotide polymorphism at residue 129 in
humans yields either methionine or valine at that position,
the nature of which affects an individual’s susceptibility to
acquired prion diseases. The 1QLX and 2W9E structures
have Met-129, whereas the 3HAK structure has Val-129.uPrP. (A) Structure alignment on the backbones of residues 128–223. (B)
ch pair of structures. Secondary structures are indicated in the bar above.
inal globular domain (portion of HB and HC, residues 175–187 and 206–
4, 137, 139, 141, 158, 161, 175, 176, 179, 180, 184, 198, 203, 205, 206,
ue shown in stick mode. To see this figure in color, go online.
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1154 Chen et al.The three huPrP structures are very similar (Fig. 1 A). In
most regions, the backbone RMSD is <2 A˚ (Fig. 1 B). In
general, the a-helices and b-strands have lower backbone
RMSD (<1 A˚) than the loops (1–2 A˚). The largest differ-
ence is at the X-loop, where the backbone RMSD is as large
as 6 A˚ for some residues. In fact, the X-loop adopts different
conformations in the three structures: it is unstructured in
the 1QLX structure, but contains a short 310 helix in the
2W9E and 3HAK structures. The 310 helix in the 2W9E
structure is shorter than in the 3HAK structure, and residues
166–170 are oriented differently in the two structures.
The N-terminal residues 90–230 of huPrP are critical for
the conversion of PrPC to PrPSc (19). Therefore, we modeled
the missing N-terminal tail (residues 90–127) as well as the
C-terminus of HC in the three structures. As a result, we ob-
tained three structures of huPrP containing residues 90–230
(Fig. 1 C). Hereafter, we refer to the three structures contain-
ing residues 90–230 by the PDB codes for the fragments:
1QLX, 2W9E, and 3HAK. We then performed multiple
all-atom, explicit-solvent MD simulations for the three
structures at two pH values (pH 7 and 5) and two tempera-
tures (298 and 310 K). We observed conformational changes
of different regions of the C-terminal globular domain,
which became more dramatic at lower pH or higher temper-
ature. We also observed the spontaneous formation of a- and
b-strands in the N-terminal region, which is a hallmark of
the conversion of PrPC to PrPSc.FIGURE 2 Changes of the C-terminal globular domain of huPrP under
different conditions. (A and B) Ca RMSD of the globular domain (A; resi-
dues 128–228) and SASA of the side chains of the hydrophobic core of the
globular domain (B; residues 134, 137, 139, 141, 158, 161, 175, 176, 179,
180, 184, 198, 203, 205, 206, 209, 210, and 213–215) averaged over the
simulations for each starting structure performed under the same
conditions.Conformational changes in the C-terminal
globular domain
The C-terminal globular domain (residues 128–228) of
huPrP is fairly stable at pH 7 and 298 K, with an average
Ca RMSD of ~2 A˚ (Fig. 2 A). The Ca RMSD of the globular
domain increased at pH 5 compared with pH 7, indicating
that instability of the globular domain was induced by
mildly acidic pH. This observation is consistent with previ-
ous experimental and computational studies (29,46,66). On
the other hand, the Ca RMSD of the globular domain was
also larger at 310 K than at 298 K, suggesting that increasing
temperature also destabilized the globular domain. The
globular domain contains a hydrophobic core consisting of
residues 134, 137, 139, 141, 158, 161, 175, 176, 179, 180,
184, 198, 203, 205, 206, 209, 210, and 213–215 (Fig. 1 C)
(67). In line with the changes of the Ca RMSD of the glob-
ular domain, the SASA of the side chains of the hydropho-
bic core increased at pH 5 (Fig. 2 B). Also, the SASA of the
hydrophobic core was larger at 310 K than at 298 K, except
for 1QLX. Again, lowering the pH or raising the tempera-
ture destabilized the globular domain.Motions of HA and the S1-HA loop
By inspecting the conformational changes in the globular
domain, we noticed that HA and its preceding S1-HABiophysical Journal 106(5) 1152–1163loop (which we have referred to as E4 in previous publica-
tions) had large displacements in some simulations, which
was the major cause of the increase of the Ca RMSD. In
the starting structures, HA is docked onto the HB-HC sub-
domain, and the S1-HA loop preceding HA interacts with
HC through hydrophobic interactions between residues
Pro-137, Ile-139, and Phe-141 on the S1-HA loop, and res-
idues Met-205, Val-209, and Met-213 on HC (Fig. 3 C). To
quantify the movement of HA with respect to the HB-HC
subdomain, we measured its Ca RMSD after alignment to
the core region of the globular domain (residues 175–187
and 206–218). By this metric, HA remained near its initial
position with its Ca RMSD of ~2 A˚ in some simulations,
whereas it moved dramatically in others (Fig. 3 A). The
large movement of HA occurred even at pH 7. For example,
in simulation 3 of 1QLX at pH 7 and 310 K, HA moved
away from the HB-HC subdomain (Fig. 3 C). However,
the magnitude of the HA displacement was different in
the three structures: the displacement of HA was largest in
FIGURE 3 Movements of HA and the S1-HA loop. (A and B) Ca RMSD of HA (A; residues 144–156) and SASA of the side chains of three hydrophobic
residues (B; Pro-137, Ile-139, and Phe-141) of the S1-HA loop averaged over entire trajectory of each simulation. Structures were aligned on the core region
of the globular domain before RMSD measurements. (C) Displacements of HA and the S1-HA loop in simulation 3 of 1QLX at pH 7 and 310 K. Snapshots
were taken at the indicated times. Residues 137, 139, 141, 205, 209, and 213 are represented in sticks. To see this figure in color, go online.
Properties of huPrP 11553HAKand smallest in 2W9E. In some simulations, themove-
ment of HA pulled the S1-HA loop away from HC, causing
exposure of the S1-HA loop to solvent (Fig. 3 C). However,
the exposure of the S1-HA loop was not always associated
with the HAmovement. For instance, although HA remained
attached to the HB-HC subdomain in simulation 2 of 2W9E
at pH 7 and 298 K, the side chain of Phe141 pointed to sol-
vent, resulting in an increase of the SASA of the S1-HA
loop without large-scale displacement of the loop (Fig. 3;
Fig. S1 in the Supporting Material). Moreover, compared
with pH 7 or 298 K, the movement of HA and the exposure
of the S1-HA loop to solvent increased at pH 5 or 310K, indi-
cating that lower pH and higher temperature promoted the
movements of HA and the S1-HA loop (Fig. 3, A and B).
We also observed the movements of HA and the S1-HA
loop away from HC in our previous MD studies
(21,26,28,29). We proposed that exposure and structuring
of the S1-HA loop may provide an aggregation site for the
formation of PrPSc oligomers, as illustrated in our spiral
models (21,23). Note that the S1-HA loop becomes an
extended strand during conversion, which we call E4 or E5
depending on the number of new N-terminal strands that
form (21,23,28). Experimental studies support our findings,
as the sequence of the S1-HA loop has a high aggregationpropensity and is indeed an initiation site for aggregation
(68). Experiments also support the MD-simulated conver-
sion, with the separation of HA and the S1-HA loop from
HC being an essential early step in the conversion of PrPC
to PrPSc (24,69). In addition, a therapeutic antibody that in-
hibits prion propagation binds to HA and the N-terminus of
HC of huPrPC, preventing the separation of HA from HC
(49). Moreover, a compound that inhibits PrPSc production
links the HA-S2 loop to the C-terminus of HB, which also
would appear to limit the movement of HA (70).Instability of the C-terminus of HB
The C-terminus of HB was stable in its a-helical conforma-
tion in most simulations at pH 7; however, it became dis-
torted in some simulations of 2W9E (Fig. 4). The
instability of the C-terminus of HB was accentuated at
pH 5. In one simulation of 1QLX, it unwound and con-
verted from a-helix to p-helix (Fig. 4 F). For 2W9E, the
C-terminus of HB partially unfolded in one simulation
and broke into two a-helices in another simulation
(Fig. S2). These results indicate that mildly acidic pH de-
stabilizes the C-terminus of HB, in agreement with previ-
ous studies (43,71,72).Biophysical Journal 106(5) 1152–1163
FIGURE 4 Instability of the C-terminus of HB. (A–C) Fraction of the a-helical conformation in time for each residue of the C-terminus of HB of 1QLX
(A), 2W9E (B), and 3HAK (C) over entire trajectory of each simulation. Secondary structures are defined according to the DSSP algorithm. (D and E) SASA
of the side chain of His-187 (D) and the number of atom-atom contacts between the side chains of His-187 and Pro-158/Met-206 (E) averaged over the entire
trajectory of each simulation. (F) Unfolding of the C-terminus of HB in simulation 1 of 1QLX at pH 5 and 310 K. Snapshots were taken at the times indicated.
His-187, Pro-158, and Met-206 are shown as sticks. To see this figure in color, go online.
1156 Chen et al.His-187 is positioned at the C-terminus of HB. It is buried
and interacts with Pro-158 and Met-206 in the starting struc-
tures (Fig. 4 F). In three simulations at pH 5, when the
C-terminus of HB was partially unfolded, His-187 became
exposed to solvent (Figs. 4 and S2). The SASA of the side
chain of His-187 increased greatly (Fig. 4 D) (except that
in one simulation, His-187 interacted with the flexible N-ter-
minal tail and maintained a lower SASA; Fig. S2 B) and its
interactions with Pro-158/Met-206 were mostly lost (Fig. 4
E). At pH 5, the side chain of His-187 was double proton-Biophysical Journal 106(5) 1152–1163ated and charged so as to affect the original packing, even-
tually causing it to become exposed, in turn leading to the
partial unfolding of the C-terminus of HB. In support of
the critical role of His-187, the H187R mutation of huPrP
causes Gerstmann-Stra¨ussler-Scheinker syndrome (73,74).Exposure of Phe-198 and Met-134 to solvent
Phe-198 is located at the HB-HC loop and is part of the
hydrophobic core of the globular domain. In the starting
Properties of huPrP 1157structures, it is surrounded by other residues, including
Arg-156, Tyr-157, His-187, Thr-188, Thr-191, Thr-192,
Glu-196, Asp-202, Val-203, and Met-206 (Fig. 5 C).
When this conformation was stable, the average SASA
of the side chain of Phe-198 was <25 A˚2; however, in
some simulations, Phe-198 became exposed to solvent
and its SASA increased to 50–150 A˚2 (Fig. 5 A). For
instance, in simulation 1 of 2W9E at pH 7 and 298 K,
the side chain of Phe-198 swung backward and its SASA
increased to 75 A˚2 (Fig. 5, A and C). These results suggest
that the packing of Phe-198 in the hydrophobic core in the
starting structures is not stable enough to remain in place
even at pH 7. The exposure of Phe-198 was more frequent
at pH 5. In an extreme case, in simulation 3 of 2W9E at
pH 5 and 310 K, the side chain of Phe-198 became fully
exposed to solvent with an average SASA of ~140 A˚2
(Fig. 5 A). These results suggest that mildly acidic pH
further destabilized the packing of Phe-198 in the hydro-
phobic core, which is consistent with our previous MD
study (29).
Met-134 is positioned at the C-terminus of S1 and is
also part of the hydrophobic core of the globular domain.
It is surrounded by Val-161, Met-213, Thr-216, and
Gln-217 in the starting structures (Fig. 5 D). Similarly
to Phe-198, Met-134 became exposed to solvent in
some simulations even at pH 7 (Fig. 5, B and D), whichFIGURE 5 Exposure of Phe-198 and Met-134 to solvent. (A and B) SASA o
trajectory of each simulation. (C) Exposure of Phe-198 to solvent in simulation 1
lation 1 of 2W9E at pH 7 and 310 K. Snapshots were taken at the indicated times
To see this figure in color, go online.illustrates the unstable packing of Met-134 in the hydro-
phobic core. However, the extent of the exposure of
Met-134 was different among the three structures.
2W9E had the most frequent exposure of Met-134 and
largest SASA. Furthermore, the exposure of Met-134
was more prevalent at pH 5 than at pH 7, indicating
that mildly acidic pH further destabilized the packing of
Met-134 in the hydrophobic core.
The exposure of Phe-198 and Met-134 to solvent contrib-
uted to destabilization of the hydrophobic core of the glob-
ular domain, which in turn contributed to partial unfolding
of huPrP and the conversion of PrPC to PrPSc. The exposed
hydrophobic side chains of Phe-198 and Met-134 also pro-
vide possible aggregation sites. In the spiral model of prion
oligomers, Met-134 is buried at the oligomeric interface and
interacts with residues at the N-termini of its own and neigh-
boring monomeric units (Fig. S3 A), and thus plays an
important role in the formation of prion oligomers (21).
On the other hand, Phe-198 is on the outside of the spiral
oligomers and does not contact any residues from other
monomeric units (Fig. S3 B). However, the exposure of
Phe-198 might aid in the aggregation between oligomers
to generate larger aggregates. In addition, the exposure of
Met-134 provides opportunities for its oxidation under
oxidative conditions, which may facilitate the conversion
of PrPC to PrPSc (75).f the side chains of Phe-198 (A) and Met-134 (B) averaged over the entire
of 2W9E at pH 7 and 298 K. (D) Exposure of Met-134 to solvent in simu-
. Phe-198, Met-134, and their neighboring residues are represented in sticks.
Biophysical Journal 106(5) 1152–1163
1158 Chen et al.Conformational changes of Tyr-169 and the X-
loop
The X-loop adopts different conformations in the starting
structures (Fig. 6 A). Located at the X-loop, Tyr-169 is
initially in different conformations with different levels of
exposure to solvent (the least in 2W9E and the most in
3HAK; Figs. 6 A and S4). In some simulations for 1QLXFIGURE 6 Conformational changes of Tyr-169 and the X-loop. (A) Starting str
(B) Alignment of the structures of Tyr-169 the X-loop at 100 ns from the simu
ulations in which the conformation of Tyr-169 was converged at 100 ns were s
backbones of residues 161–163 and 172–175. (C) RMSD of the backbone (N
2W9E. RMSD at 100 ns (open circle) was averaged over all pairs of selected sim
structures of 1QLX and 2W9E (open square). (D) Converged conformation of
1QLX at pH 7 and 298 K. Tyr-169 and surrounding residues are shown as sti
Tyr-169 in which it is buried. A representative structure was taken at 100 ns of sim
Biophysical Journal 106(5) 1152–1163and 2W9E (five and 10 simulations for 1QLX and 2W9E,
respectively), the X-loop converged to a common conforma-
tion (Fig. 6 B). Initially, the backbone RMSD between
1QLX and 2W9E was as large as 5 A˚ for some X-loop res-
idues (Fig. 6 C). At the end of the simulations, the backbone
RMSD decreased substantially (Fig. 6 C). In the converged
conformation of the X-loop, Tyr-169 hydrogen bonded touctures of Tyr-169 and the X-loop. Tyr-169 and Asp178 are shown as sticks.
lations of 1QLX to those from the simulations of 2W9E. Five and 10 sim-
elected for 1QLX and 2W9E, respectively. Structures were aligned on the
, Ca, C, and O atoms) of each residue of the X-loop between 1QLX and
ulations as in panel B. The initial RMSD was measured between the crystal
Tyr-169. A representative structure was taken at 100 ns of simulation 2 of
cks. Dashed lines indicate hydrogen bonds. (E) Different conformation of
ulation 1 of 3HAK at pH 7 and 298 K. To see this figure in color, go online.
Properties of huPrP 1159Asp-178 and interacted with Phe-175 (Fig. 6 D). This
conformation of Tyr-169 was highly populated and very sta-
ble for 2W9E, so that Tyr-169 seldom sampled other con-
formations (Fig. S4). A recent experimental study
suggested that a similar conformation of the X-loop in
mouse PrP is dominant, with a >90% population (76).
Only at pH 5 and 310 K did Tyr-169 adopt other confor-
mations and become exposed to solvent, indicating that
mildly acidic pH and the increase in temperature destabi-
lized the most populated conformation. In line with this
observation, pathogenic mutations have been shown to
induce the exposure of Tyr-169 (39,42). In the spiral olig-
omer model, Tyr-169 formed multiple contacts with resi-
dues from neighboring monomeric units (Fig. S3 C),
contributing to the formation of oligomers (77). In contrast
to 1QLX and 2W9E, Tyr-169 rarely formed hydrogen
bonds with Asp-178 in the simulations of 3HAK
(Fig. S4). However, Tyr-169 frequently sampled another
largely buried conformation (low SASA), where it inter-
acted with Tyr-163, Phe-175, Tyr-218, and Tyr-225
(Fig. 6 E).Formation of a- and b-strands in the N-terminal
tail
The N-terminus of huPrP (residues 90–127) was unstruc-
tured in the starting structures (Fig. 1 C). However, in the
simulations, we observed the formation of a- and
b-strands in the N-terminus, which is a sign of the conver-
sion of PrPC to PrPSc (Fig. 7). a-Strands, including
a-bridges, formed mainly in two regions: residues 90–
100 and residues 110–127 (Fig. 7, A–C). For example,
in simulation 2 of 1QLX at pH 5 and 298 K, an a-sheet
containing two strands started to form in the first region at
~20 ns and was stable through the rest of the simulation
(Fig. S5, A and C). The population of a-strand in the first
region was higher at pH 5 than at pH 7, but the opposite
occurred in the second region. Compared with the two
structures with Met-129 (1QLX and 2W9E), a-strand
seldom formed in the second region for 3HAK, indicating
the effect of polymorphism at residue 129 (methionine for
1QLX and 2W9E, and valine for 3HAK). Consistently, in
previous simulations of huPrP under strongly acidic
conditions (pH < 4), a-sheet also formed in residues
90–100 (28). a-Sheet has been observed in many simula-
tions of amyloidogenic proteins, including PrP, and we
have postulated that it is an intermediate during the for-
mation of amyloid and is associated with toxicity
(21,28,38,78–84).
On the other hand, b-strands, including b-bridges, pre-
dominantly formed over residues 110–127 (Fig. 7, D–F).
For instance, in simulation 2 of 3HAK at pH 5 and 310
K, a b-strand formed and added to the native S1/S2
b-sheet, resulting in a three-stranded b-sheet (Fig. S5, B
and D). This result is in agreement with our previousMD simulations (21,28,29,40). Furthermore, the elongation
of the native b-sheet is consistent with the increase of the
b-sheet content in the conversion of PrPC to PrPSc
observed by experiments (17,18). b-Strands also formed
in residues 90–100, but much more rarely than in residues
110–127.
The spontaneous formation of a- and b-strands in the
N-terminal tail observed in our simulations supports that
the idea that the conversion of PrPC to PrPSc can occur spon-
taneously, which presumably is a major factor in sporadic
prion diseases. It also suggests that the N-terminal tail plays
a critical role in the conversion of PrPC to PrPSc. Consis-
tently, the spiral model predicts the N-terminus to be a crit-
ical aggregation site (21,23). In addition, peptides derived
from the N-terminus have highly amyloidogenic properties
and are able to inhibit the conversion of PrPC to PrPSc
(85,86). Finally, truncation removing the N-terminus ren-
ders the protein benign (87), whereas removal of the last
two helices does not (88).CONCLUSIONS
We performed extensive MD simulations for three
different structures of the wild-type huPrP. We observed
conformational changes in different regions of the
C-terminus globular domain in the simulations (Fig. 8).
HA and the S1-HA loop underwent large displacements
away from the HB-HC subdomain, an early step in the
conversion of PrPC to PrPSc. The C-terminus of HB was
unstable and unfolded in some simulations. In addition,
two residues in the hydrophobic core of the C-terminal
globular domain, Phe-198 and Met-134, were very flexible
and sometimes exposed to solvent. These conformational
changes were facilitated at lower pH or higher tempera-
ture. Furthermore, although they were different in the
starting structures, Tyr-169 and the X-loop converged to
common, highly populated conformations for the two
structures with Met-129, but not the structure with Val-
129. Finally, a- and b-strands formed in the N-terminal
tail, a sign of the conversion of PrPC to PrPSc. a-Strands
formed mainly in two regions (residues 90–100 and 110–
127) for the two structures with Met-129, but rarely in the
second region for the structure with Val-129. b-Strands
formed predominantly in residues 110–127 for all three
structures. These results are consistent with many previ-
ous experimental and computational studies. They also
suggest that huPrPC is intrinsically unstable and can
convert spontaneously. The detailed structural and dy-
namic properties of huPrP obtained in this study shed
further light on the mechanism of the conversion of
PrPC to PrPSc. Furthermore, individuals with Met-129
are more susceptible to prion diseases than those with
Val at that position. These results hint at dynamic struc-
tural differences between the polymorphs that may be
relevant to disease susceptibility.Biophysical Journal 106(5) 1152–1163
FIGURE 7 Formation of a- and b-strands in the N-terminal tail. (A–F) Fraction of a-strand (A–C; including a-bridge) or b-strand (D–F; including
b-bridge) in time for each residue of the N-terminus (residues 90–127) of 1QLX (A and D), 2W9E (B and E), and 3HAK (C and F) over all three simulations
(i.e., 300 ns) for each condition. Secondary structures are defined according to the DSSP algorithm. To see this figure in color, go online.
Biophysical Journal 106(5) 1152–1163
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FIGURE 8 Schematic illustrating the major conformational changes
observed during MD mapped onto the (90–230) M129 human PrPC struc-
ture. The six major changes discussed in the text are denoted on the affected
regions of the protein by colors and labels. To see this figure in color, go
online.
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